毕得医药：股东欣曦管理、兰旦管理及其一致行动人拟减持股份

Core Viewpoint - Bid Pharma (688073.SH) announced a share reduction plan by its shareholders due to personal liquidity needs, involving multiple parties and specific share quantities to be sold through different trading methods [1] Group 1: Shareholder Reduction Plans - Shareholder Xinxin Management plans to reduce its holdings by up to 1,036,065 shares through block trading, representing 1.14% of the total share capital, and up to 363,532 shares through centralized bidding, representing 0.40% of the total share capital [1] - Shareholder Landan Management intends to reduce its holdings by up to 781,593 shares through block trading, representing 0.86% of the total share capital, and up to 363,532 shares through centralized bidding, also representing 0.40% of the total share capital [1] - Shareholder Wu Bo plans to reduce his holdings by up to 181,766 shares through centralized bidding, representing 0.20% of the total share capital [1]